A systematic review of the relationship between subclinical small vessel disease (SSVD) in the general population and apathy to examine the hypothesis that apathy has a vascular basis.
| INTRODUCTION
Apathy, or diminished motivation, has traditionally been regarded as a symptom of psychiatric and neurological disorders, such as major depressive disorder 1 and Parkinson's disease. 2 Apathy has increasingly come to be regarded as an independent syndrome for which diagnostic criteria have been proposed in a consensus paper. 3, 4 With its prevalence in the general population (≥50 years) being estimated 5 at 23.7%, the impact of apathy on both individuals and the society is extensive. The apathy syndrome negatively affects motivational decision making 6 and is associated with functional decline, 5 reduced engagement in activities of daily living, and a poorer quality of life. 7 Understandably, apathy is very distressing for family and other caregivers. 8 The hypothesis of vascular apathy assumes a relationship between the generally widespread cerebrovascular damage caused by small vessel disease (SVD) and apathy. 9, 10 Whether cerebrovascular damage due to SVD is associated with apathy-even in the general population without prior knowledge of cerebrovascular damage-is the main subject of this study.
Various brain circuits play a role in planning, motivation, and autoactivation; among which are the frontal regions with their projections to prefrontal regions and the basal ganglia, the parietal regions, and the anterior cingulate. 11 The vascular apathy hypothesis then supposes that SVD can cause apathy by damaging these tracts. However, the relationship between vascular disease and apathy could well be bidirectional: A recent systematic review and meta-analysis 12 showed that apathy increases the risk of myocardial infarction by 21%, stroke by 37%, and even mortality by 47%. In the populations evaluated, these risks might additionally or alternatively be raised because of the participants' adverse health behaviors and low adherence to treatment regimens for vascular disease. [13] [14] [15] Moreover, apathy and vascular disease might have a shared etiology, 16 while apathy could well be a marker of subclinical SVD (SSVD). 14 Early evidence for the vascular apathy hypothesis was reported in studies in clinical samples with established cerebrovascular disease (eg, vascular dementia and stroke), where apathy appeared related to the general effect (or severity) of cerebrovascular damage, given that associations with specific cerebral circuitries and regions were inconsistent. 17, 18 Particularly, the stroke subtype of SVD (lacunar infarcts and white matter hyperintensities [WMH]) was found to be related to apathy in several other studies, independent of depression. [19] [20] [21] Indirect and also contradictory evidence came from research into late-life depression, where chronicity of late-life depression was found to be associated with the severity of the risk factors for cerebrovascular disease and apathy. 22 Still, although the presence of apathy was predicted by vascular factors in several elderly depressed populations, 23 other studies found no such associations. 1, 24 Moreover, depression itself could be related to vascular factors, as the so-called vascular depression hypothesis postulates, 25 which complicates the interpretation of findings pertaining to vascular apathy in depressed populations.
Other indirect evidence seems to support the existence of vascular apathy in that a negative interaction was observed between neuroticism and cerebrovascular risk factors in the prediction of depression, suggesting that apathy caused by SSVD might attenuate the depressogenic effect of neuroticism. 10, 26 Obviously, more convincing and direct evidence of vascular apathy could come from research investigating the apathy-SSVD relationship in the general population, given that cerebral SVD develops from a subclinical condition, increasing the risk on overt cerebrovascular disease, [27] [28] [29] [30] where, although still subclinical, SSVD might cause subtle signs and symptoms, like mild disturbances in gait, cognitive functioning, and mood. 27 The aim of the present systematic review is to examine all the evidence supporting an association between SSVD and apathy in the general population, while also considering findings of associations between proxies of SSVD and apathy. and checked by the second author (MvK). Differences in findings were analyzed, and discrepancies were discussed between both authors (LW and MvK), and when no consensus could be reached, a third author (RM) was asked to make the final judgment. Two more eligible articles were identified while preparing a speech on apathy using the search terms "apathy" and "dementia." 31, 44 On inspection, these two studies also reported on the general population or populations with minimal cognitive impairment (MCI), which is why we included them in our review.
Articles were included when (a) apathy was assessed by any kind of relevant instrument; (b) SSVD was based on either neuroimaging,
Key points
• Hypertension and cardiovascular disease, proxies for SSVD, are associated with apathy.
• White matter hyperintensities, a direct measure of SSVD, are associated with apathy.
• Prospective evidence of the associations between SSVD and apathy is scarce.
• Further research into the SSVD-apathy relationship from prospective studies is warranted, preferably controlled for depression. considered a direct measure of SSVD, or peripheral measures of atherosclerosis, considered as proxies for SSVD; and (c) studies reported on observational epidemiological research and (d) were performed in the general population. This implies that studies in broad patient groups or the general population including those with minimally cognitively impaired patients were included in the review.
Studies were excluded (a) when the language was not English and (b) when the studies concerned specific populations, such as poststroke patients and patients with dementia (including vascular dementia), with Parkinson's disease, or with major depression.
| Study quality
The quality of the case-control, cross-sectional, and longitudinal studies selected for review was judged against specific criteria for design and methodology. We used an adapted version of the evaluation scale for cross-sectional (not case-control) studies originally developed by Kuijpers et al 32 (Data S1). For case-control and longitudinal studies, we used scales based on the Newcastle-Ottawa scale 33 (Data S2).
Overall quality of a study was considered high when it attained at least 60% of the maximum score. 34 
| Evaluation of the quality of apathy scales
The apathy evaluation scale (AES) and the apathy subscale of the neuropsychiatric inventory (NPI) were considered of high quality. 35, 36 The three apathy items of the geriatric depression scale are validated by comparison with the apathy scale (sensitivity 69% and specificity 85%). 29, 37 The apathy scale (an abbreviated version of the AES) and therefore also the apathy items of the GDS were not granted the highest quality status in our evaluation based on the review by Clarke et al. 36 Clinician-or informant-based information was considered of higher quality than self-reported in the older population where individuals may have been suffering from MCI. 38 
| Evaluation of the quality of SSVD assessment
SSVD on neuroimaging was operationalized as WMH, silent lacunar infarcts, cerebral microbleeds, or decreased cortical thickness on MRI scans. 27 Diffusion tensor imaging (DTI) studies the diffusivity of water molecules in white matter as a model of the connectivity of this tissue and its markers (fractional anisotropy [FA] and diffusivity) are associated with SVD. 39 Peripheral measures of atherosclerosis were operationalized as the ABI, IMT, and/or CFPWV. Although the ABI and CFPWV are measures of large artery atherosclerosis, 40 we considered both measures proxies for SSVD as large artery and SVD are closely related. 41 Cardiovascular disease was included as an SSVD proxy, since it can lead to hemodynamic changes affecting the small vessels. 41 Finally, being the strongest risk factor for SSVD, hypertension was also taken as an SSVD proxy. 27, 41 Studies were awarded an extra point if SSVD proxies were measured rather than mentioned in an interview or derived from information provided by general practitioners. Self-reported SSVD was categorized as "low quality."
| RESULTS
The results of the search strategy are shown in the flow chart depicted in Figure 1 . No relevant studies published before 1990 were found. Of the 14 studies included in the review, one study reported on both peripheral proxies and direct measures of SSVD, 30 four studies on peripheral proxies of SSVD only, 9, 29, 42, 43 and finally, nine studies on direct measures of SSVD only. 31, [44] [45] [46] [47] [48] [49] [50] [51] 
| SSVD and apathy
In Table 1 , the five studies that used peripheral proxies for SSVD are listed and details and results are described. A meta-analysis of the results was not possible, because the research designs, SSVD proxies, and methods of ascertaining apathy that had been used differed too widely.
Three studies examined associations between hypertension and apathy 9, 30, 42 ; two of which found a significant link with systolic blood pressure, 9, 42 and the other with the diastolic (but not systolic) blood pressure. 30 This latter study 30 In their large-scale study, Ligthart et al 9 found an odds ratio (OR) of 1.28 in their participants with cardiovascular disease (1.09-1.52; P = .004). The number of cardiovascular pathologies in another large and prospective study 29 was found to be associated with apathy at baseline and with incident apathy during follow-up.
Finally, ABI was associated with apathy, 42 but arterial stiffness (CFPWV) was not. 43 
| Neuroimaging and apathy
The 10 studies using MRI or DTI are presented in Table 2 .
Of the three studies examining the association between WMH and apathy, the two cross-sectional studies found a significant association, 30, 48 whereas the (smaller) case-control study did not. 49 Again, a meta-analysis and quantitative estimation of the WMH and apathy association were not possible, because of the large differences in the studies' research designs, the methods of ascertaining WMH (number or volume), and apathy scales used. It needs to be noted here that, with 4354 participants, the study by Van Grool et al 48 would have largely outweighed the findings of the other studies in any meta-analysis, since the other studies had much smaller samples.
Mean white matter diffusivity (MD) was associated with apathy in specific areas in the small-scale study by Cacciari et al, 45 but not in the study by Moonen et al. 50 Other DTI measures (FA, axial diffusivity, and radial diffusivity) were not associated with apathy. 50 Evaluating the data of 802 participants, Xu et al 51 found the participants who had suffered a single cerebral microbleed to show significantly more apathy than participants without cerebral microbleeds.
Of the three studies examining looking at cortical thickness and apathy, two studies found an association between apathy and a reduced thickness of the temporal lobe. 32, 33 No associations were reported for apathy and the entorhinal cortex, the orbitofrontal cortex, or the middle frontal gyrus, 47 while no association or even an inverse association was found between apathy and the anterior cingulate. 31, 47 However, in a model in which apathy was adjusted for depressive symptom severity, apathy was found to be associated with a more rapid reduction of the anterior cingulate cortex during follow-up. 47 
| DISCUSSION

| Main findings
The results of our review indeed support the hypothesis that SSVD is related with apathy. More specifically, as peripheral proxies for SSVD, hypertension and cardiovascular disease were consistently found to be associated with apathy. 9, 29, 30, 42 With the only study examining ABI finding a significant association with apathy while another single study focusing on arterial stiffness did not, 42, 43 the results with respect to other peripheral measures of atherosclerosis were inconclusive. Apathy was, however, also linked to cerebral microbleeds 51 and WMH load. 30, 48 SSVD was related to white MD; however, a direct association between white MD and apathy has not been established yet. 45, 50 The evidence on the relationship between cortical thickness and apathy is inconclusive. 31, 44, 47 
| Hypertension, cardiovascular disease, WMH, and apathy
Both systolic and diastolic blood pressure were associated with apathy, 9, 30, 42 while associations between WMH and apathy (and cerebral their study may have been underpowered. Finally, cardiovascular disease was firmly associated with apathy, not only cross sectionally but also longitudinally. 9, 29 Although its etiology is not fully understood, WMH reflects ischemic arteriolosclerosis in the brain 27 and is related to congenital heart disease, hypertension, carotid blood flow, diabetes, and cardiovascular health. 52 WMH may then be seen as consequence of chronic hypoperfusion as well as impaired cerebrovascular reactivity. Nonetheless, blood-brain-barrier leakage and myelin-remodeling problems could play a role. 53 The relation between hypertension, cardiovascular disease, and WMH could be limited blood flow to the brain and/or arterial stiffness. [52] [53] [54] How SSVD can lead to apathy is not yet fully understood. Destruction of limbic or reward pathways is considered as a potential cause.
Indeed, apathy was found to be associated with impaired connectivity of limbic association tracts in patients with clinical SVD. 55 The results of the DTI studies of white matter connectivity and apathy in SSVD, however, were not conclusive. 45, 50 
| Cortical thinning, SSVD, and apathy
The contradictory findings regarding the relationship between cortical thickness and apathy might be due to other mechanisms than SSVD leading to cortical thinning. Cortical thickness and WMH are associated, but they are not interchangeable. 56, 57 Cortical thinning in the parietal lobes, anterior insula, and caudate nuclei bilateral is related to WMH, but widespread cortical thinning is related to normal aging as well as early Alzheimer's disease. [56] [57] [58] In the frontal regions, the temporal regions, and the anterior cingulate, all areas that have been studied specifically, cortical thinning could be caused by aging as well as Alzheimer's disease. Our review has shown that associations in the general population between apathy and the WMH-related regions of cortical thinning (parietal lobes, anterior insula, and caudate nuclei) have not been studied yet. This is a consideration for future research, more than it is a counterargument for an association between SSVD and apathy.
| The vascular apathy hypothesis and the vascular depression hypothesis
Depression can be a confounder when looking for the relationship between vascular disease and apathy, since apathy may be a symptom of depression (anhedonia), while it has also been related to vascular disease. 25, 59 Of the 14 studies we reviewed, 12 controlled for depression. 9, [29] [30] [31] [42] [43] [44] [45] 47, [49] [50] [51] In three of these latter studies, the GDS was used as a measure of both apathy and depression, 9, 29, 43 and in five articles, 31, 44, 47, 49, 50 the GDS was used as a measure of depression, including the three apathy items of this scale. Since these GDS apathy items show a low sensitivity and a high specificity as a measure of apathy in older populations, 37 correction for depression measured by the GDS may imply that apathy was also corrected for attenuating the SSVDapathy association. If depression was overcorrected for in these studies, the associations between SSVD and apathy may also have been stronger than the statistics now shown. On the other hand, the role of apathy in the vascular depression hypothesis is often not accounted for in research, while it may potentially act as a confounder. In patients with clinical SVD, apathy was associated with reduced white matter integrity, while depression was not, when apathy was controlled for. 19, 21 Arguably, with the emerging evidence for the vascular apathy hypothesis, one may wonder whether in research of the vascular depression hypothesis apathy was and is adequately corrected for.
| LIMITATIONS
As stated, most of the research we reviewed was cross sectional, preventing us from establishing whether SSVD precedes apathy, while we were also unable to determine whether more SSVD leads to higher levels of apathy. An alternative explanation for an apathy-SSVD or an SSVD-apathy relationship in cross-sectional designs is that apathy leads to poorer cardiovascular outcomes because of differences in health behaviours. 14 Does an association between CVRF and apathy then reflect the concept of vascular apathy our does it (partially) reflect differences in health behaviors that are caused by apathy? Nevertheless, the findings of an increase in the incidence of apathy with more cardiovascular pathologies 29 point towards CVRF as an etiological factor in apathy (and not only the reverse mechanism).
Another methodological issue is the use of many different proxies for SSVD. The use of a broad array of SSVD proxies has negative consequences for the comparability of the research and precludes metaanalysis to estimate the magnitude of associations found. Nonetheless, generalizability increases when increasing levels of apathy are associated with widely different proxies for SSVD.
Finally, of the many different apathy scales that were employed, the AES and the NPI apathy subscale were the only tools that are well validated, 35, 36 which is why we cannot rule out that the use of the other apathy scales may have negatively affected the quality of the results reported.
| CONCLUSION
The studies published to date show that WMH, cerebral microbleeds, cardiovascular disease, hypertension, and ABI are associated with apathy in the general population. However, as most studies were cross sectional in nature, the directions of the associations remain unclear and might be reciprocal/bidirectional. Finally, although the hypothesis of vascular apathy is supported by the available literature, more prospective evidence is needed.
